Back to Home
Personalized Medicine Approach

Melanoma ResearchAI Factory Pipeline

Our 13-agent AI pipeline analyzes Cannflavin A's potential as a melanoma treatment, organized into 5 specialized intelligence categories.

Foundational Plant AI

Guided Outcome Control

Pre-Processing: Seed → Lab

Seed Genetic Testing
Environmental Testing
Tissue Culture QC
ChIP-Seq Analysis

Honest Assessment Standard Operating Protocols

Quality gate before Discovery Engine entry — data integrity, traceability & reproducibility verified

Foundational Plant AI

Guided Outcome Control

Human Protein Network

RSK2PIM1BRAFMEK1ERK2

Molecular Docking

ASP107LEU173ILE9LYS59PHE38VAL57

Docking Reasoning Agent

RSK2PIM1BRAFCOX-2

Molecular Dynamics

40ns60ns80ns100ns

Toxicity Prediction

hERGAMESHepatoCardioMuta

Dissolving Agent

DMFDMSOEtOAcMeOHH₂O

Shelf Life

03612

Nanoparticle Size

TPGSPVAPVPP188

Lipid Bioavailability

RawSLNNLCLiposome

Excipients Risk QC

TPGSLecithinMCTPEG400

Cancer Reasoning Agent

K-562A375SK-MELB16F10MCF7HeLa

Chemical Patent Agent

IND Application Agent

CMCPharmToxClinical

Mother Nature AICannflavin A Expert

Ask about melanoma research

Try asking:

Real-World Evidence

Post-Market Data Collection

📊

Patient Outcomes

Registry & EHR integration

📈

Safety Signals

Pharmacovigilance monitoring

📉

Efficacy Tracking

Comparative effectiveness

📋

Claims Data

Healthcare utilization

User Access Layer• API Interface